Get informed when a big investor buys or sells
+ FollowOvervalued by 133.2% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $11.66 Million |
|---|---|
| Enterprise Value | $12.36 Million |
| Earnings per Share | $-0.04 |
| Beta | -0.93 |
| Outstanding Shares | 12,783,165 |
| P/E Ratio | -20.31 |
|---|---|
| PEG | 28.08 |
| Price to Sales | - |
| Price to Book Ratio | -0.91 |
| Enterprise Value to Revenue | 157.89 |
| Enterprise Value to EBIT | -139.59 |
| Enterprise Value to Net Income | -88 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | -0.65 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
CYduct Diagnostics, Inc. operates as a medical instrument enterprise that engineers and commercializes a diverse range of technologies, equipment, and methodologies. These innovations are purposed for the detection, diagnosis, therapeuti...